Burek, Malgorzata
König, Anna
Lang, Mareike
Fiedler, Jan
Oerter, Sabrina
Roewer, Norbert
Bohnert, Michael
Thal, Serge C.
Blecharz-Lang, Kinga G.
Woitzik, Johannes
Thum, Thomas
Förster, Carola Y.
Funding for this research was provided by:
FP7 Science in Society (HEALTH-F2-2009-241778)
Article History
Received: 11 June 2018
Revised: 26 November 2018
Accepted: 21 December 2018
First Online: 8 January 2019
Compliance with Ethical Standards
:
: TT filed and licensed patents about noncoding RNAs including miR-212/132 through the Medical School Hannover. TT founded and holds shares in the biotech company Cardior Pharmaceuticals GmbH. All the other authors declared that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.